吻合器痔上黏膜环切术加外痔切除术治疗重度混合痔的临床效果观察(2)
针对重症混合痔患者的治疗，采用吻合器痔上黏膜环切术联合外痔切除术治疗，能显著改善手术相关指标，促进患者术后恢复，且术后并发症较少，可在临床大力推广和使用。
参考文献
[1]朱燕辉，黄丽霞，颜景颖，等.吻合器痔上黏膜环切术加外痔切除术治疗混合痔的临床研究[J].实用医学杂志，2008，24(20)：3515-3516.
[2]罗维民，李玉英，胡丰良，等.吻合器痔上黏膜环切术加外痔切除术治疗重度混合痔的效果[J].实用医学杂志，2008，24(2)：213-215.
[3] Kweekel D M，Antonini N F，Nortier J W，et al.Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array[J].Br J Cancer，2009，101(2)：357-362.
[4] Sileri P，Dugo S，Bennavoli D，et al.Metachronous splenic metastasis from colonic carcinoma five years after surgery：A ease report and literature review[J].South Med J，2009，10(27)：733.
[5] Nouguerède E，Berenguer C，Garcia S，et al.Expression ofadrenomedullin in human colorectal tumors and its role incell growth and invasion in vitro and in xenograft growth invivo[J].Cancer Med，2013，879(20)：196-207.
[6] Pasquale C，Antonio G，Antonio F，et al.A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma[J].Critical Reviews in Oncology/Hematology，2005，53(2)：133.
[7]盛小燕.PPH術联合聚桂醇硬化注射术治疗混合痔观察及护理[J].实用中医药杂志，2013，24(10)：859-860.
[8] Shi S B，Hu R H，Qi J L，et al.Treatment of stage Ⅲb/Ⅳ nonsmallcell lung cancer with pemetrexed plus oxaliplatinafterfailure of erlotinib as second-line treatment[J].Med Oncol，2013，30(2)：550.
[9]马广友，刘延锋.吻合器痔上黏膜环切术联合外痔切除术治疗Ⅲ、Ⅳ度混合痔80例疗效观察[J].山东医药，2010，50(51)：97-98.
[10] Fushida S，Oyama K，Kinoshita J，et al.VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer：prognostic significance of VEGF in ascites and efficacy of anti-VEGFmonoclonal antibody[J].Onco Targets Ther，2013，16(6)：1445-1451.
(收稿日期：2016-10-10), http://www.100md.com(赵文静)
参考文献
[1]朱燕辉，黄丽霞，颜景颖，等.吻合器痔上黏膜环切术加外痔切除术治疗混合痔的临床研究[J].实用医学杂志，2008，24(20)：3515-3516.
[2]罗维民，李玉英，胡丰良，等.吻合器痔上黏膜环切术加外痔切除术治疗重度混合痔的效果[J].实用医学杂志，2008，24(2)：213-215.
[3] Kweekel D M，Antonini N F，Nortier J W，et al.Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array[J].Br J Cancer，2009，101(2)：357-362.
[4] Sileri P，Dugo S，Bennavoli D，et al.Metachronous splenic metastasis from colonic carcinoma five years after surgery：A ease report and literature review[J].South Med J，2009，10(27)：733.
[5] Nouguerède E，Berenguer C，Garcia S，et al.Expression ofadrenomedullin in human colorectal tumors and its role incell growth and invasion in vitro and in xenograft growth invivo[J].Cancer Med，2013，879(20)：196-207.
[6] Pasquale C，Antonio G，Antonio F，et al.A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma[J].Critical Reviews in Oncology/Hematology，2005，53(2)：133.
[7]盛小燕.PPH術联合聚桂醇硬化注射术治疗混合痔观察及护理[J].实用中医药杂志，2013，24(10)：859-860.
[8] Shi S B，Hu R H，Qi J L，et al.Treatment of stage Ⅲb/Ⅳ nonsmallcell lung cancer with pemetrexed plus oxaliplatinafterfailure of erlotinib as second-line treatment[J].Med Oncol，2013，30(2)：550.
[9]马广友，刘延锋.吻合器痔上黏膜环切术联合外痔切除术治疗Ⅲ、Ⅳ度混合痔80例疗效观察[J].山东医药，2010，50(51)：97-98.
[10] Fushida S，Oyama K，Kinoshita J，et al.VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer：prognostic significance of VEGF in ascites and efficacy of anti-VEGFmonoclonal antibody[J].Onco Targets Ther，2013，16(6)：1445-1451.
(收稿日期：2016-10-10), http://www.100md.com(赵文静)